[#item_full_content]LOS ANGELES–(BUSINESS WIRE)–SpectrumAi, a company developing innovative solutions to improve autism care, today announced that it closed up to $20 million in Series A funding led by CVS Health Ventures with participation from Cobalt Ventures, and follow-on investments from Seed investors F-Prime, Frist Cressey and Autism Impact Fund. Financing will accelerate adoption of SpectrumAi’s applied behavior analysis (ABA) electronic health record, Twyll, and Patterns, its network analytics platform,